Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel GABA-A receptor ligands in early development at Neurogen

June 23, 2004

ExonHit develops improved formulation of Ikomio

June 23, 2004

Guilford licenses U.S. rights to GPI-1485 to Symphony Neuro Development Company

June 22, 2004

Potent in vivo antinociceptive effects of orally active agent by Mochida

June 22, 2004

Guilford patent covers new DPPIV inhibitors and their therapeutic use

June 21, 2004

Results from confirmatory phase II study of Aquavan

June 21, 2004

Copaxone PFS available in Europe

June 21, 2004

Targeting of Nurr1 gene promising for Parkinson's disease therapy

June 21, 2004

Data on the pharmacokinetics of ramelteon presented at sleep conference

June 21, 2004

Improved prevention of CINV found with a palonosetron combination therapy

June 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026